Biogen Q1 2024 results surpass expectation despite revenue decline

Follow Invezz on Telegram , Twitter , and Google News for instant updates >Biogen Inc. (NASDAQ: BIIB), a leading biotechnology company, has released its Q1 2024 financial results, showcasing resilience and strategic growth despite facing revenue challenges.Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.In the first quarter of 2024, Biogen reported a revenue of $2.29 billion, which slightly missed expectations by $30 million. However, the company demo ...